Network with MHRA, Sandoz, Boehringer Ingelheim, Merck Serono, Sanofi, Teva, AbbVie, Italfarmaco S.p.A., Mundipharma International and more | Biosimilars and Biobetters
SMi's 6th annual Biosimilars and Biobetters conference, taking place on 30th September - 1st October 2015 in London, will cover regulatory updates, Biosimilars pharmacovigilance, patent litigation, market access, product commercialisation barriers and global market developments.
- (1888PressRelease) September 24, 2015 - With the event now 1 week away, I would like to remind you that this is the final chance to secure a place for SMi's 6th annual conference on Biosimilars and Biobetters, taking place on the 30th September - 1st October 2015 in Central London.
Following the breakthroughs in the US, this is the only European Biosimilars and Biobetters meeting which gathers global industry experts to discuss the latest issues with technical case studies. You will hear regulatory updates and developments in the biosimilar commercial environment from MHRA, Merck Serono, Teva, Cinfa Biotech, Norwegian Medicines Agency and many more.
Don't miss out on this 2-day conference which includes:
16 case studies + 2 in-depth workshops to drive commercial success
2 interactive panel discussions to learn from your industry colleagues
3 hours of valuable networking sessions
Meeting biosimilars leaders outside of Europe
View the full speaker line-up and two-day conference programme at http://www.biosimilars-biobetters.co.uk/1888pressrelease
Update on Confirmed Attendees
Join us next week and network with Biosimilars and Biobetters professionals from:
AbbVie
Alston & Bird LLP
Anteris Medical GmbH
Arnold & Porter LLP
Boehringer Ingelheim
Bristows
Cinfa Biotech
Ecole Normale Supιrieure de Cachan
Eppendorf AG
Fresenius Kabi
GfK
Globyz Pharma
Grifols
IMS Health
Invest Lithuania
Italfarmaco S.p.A.
Kantar Health
Kinesys Consulting
Merck Serono
MHRA
Mundipharma International
Newcastle University
Norwegian Medicines Agency
Orion Corporation
Salamanca Group
SAI MedPartners
Sandoz
Sanofi
Schwegman, Lundberg & Woessner
Selecta Biosciences
SGS Life Sciences Services
SGS M-Scan SA
Teva
University of Basel
Venner Shipley LLP
Wyatt Health Management
plus many more....
Plus, don't miss two interactive conference workshops:
Workshop A | 1:00pm - 5.30pm | 29th September 2015
Assessing the Regulatory Framework for Europe and the US - Developing Future Biologics
Led by: Fiona Greer, Global Director, Biopharmaceutical Services Development, SGS M-Scan SA and Lincoln Tsung, Daniel Kracov, Jennifer Sklenar, Partners, Arnold & Porter (UK) LLP
Workshop B | 8:30am - 12.30pm | 2nd October 2015
Biosimilars - Understanding the Regulatory Processes and the Commercial Realities
Led by: Peter Wittner, Senior Consultant, Interpharm Consultancy
###
space
space
Contact Information
- Vinh Trinh
- Smi Group
- Unit 122/124 Great Guildford Business Square, 30 Great Guildford Street, London
- SE1 0BS
- Voice: 44 (0) 20 7827 6140
- Visit our Site
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam